Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta

被引:257
作者
Baquet, ZC
Bickford, PC
Jones, KR
机构
[1] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA
[2] Univ S Florida, James A Haley Vet Affairs Hosp, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA
基金
英国惠康基金;
关键词
BDNF; substantia nigra pars compacta; Parkinson's disease; mouse; Cre-lox; stereology; neurotrophin;
D O I
10.1523/JNEUROSCI.4601-04.2005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Brain-derived neurotrophic factor ( BDNF) has been implicated in regulating neuronal survival, differentiation, and synaptic plasticity. Reduced expression of BDNF within the substantia nigra accompanies the deterioration of dopaminergic neurons in Parkinson's disease (PD) patients. Analysis of the effects of long-term BDNF absence from the CNS has been difficult because of the early postnatal lethality of BDNF (+/-) mice. Mice with a floxed BDNF allele were bred with Wnt1-Cre mice to generate Wnt-BDNFKO mice that lack BDNF from the midbrain-hindbrain (MHB). These mice are viable but exhibit hindlimb clutching and poor rotarod performance. Tyrosine hydroxylase (TH)-positive neuron numbers in the substantia nigra pars compacta (SNC) were estimated using stereological methods, revealing a persistent similar to 23% reduction of these cells at postnatal day 21 (P21) in Wnt-BDNFKO mice compared with controls. The diminishment of TH-expressing neurons was present at birth and continued through P120. This deficit appears selective for the dopaminergic population, because at P21, total neuron number within the SNC, defined as neuronal nuclei protein-positive cells, was not significantly reduced. Interestingly, and similar to observations in PD patients, SNC neuron subpopulations are not equally affected. Calbindin- and calretinin- expressing SNC populations show no significant difference between Wnt-BDNFKO mice and controls. Thus, BDNF depletion from the MHB selectively leads to reduced TH expression in a subpopulation of neurons, but it remains unclear whether these cells are lost.
引用
收藏
页码:6251 / 6259
页数:9
相关论文
共 99 条
[11]   Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain [J].
Chauhan, NB ;
Siegel, GJ ;
Lee, JM .
JOURNAL OF CHEMICAL NEUROANATOMY, 2001, 21 (04) :277-288
[12]  
Conover JC, 1997, REV NEUROSCIENCE, V8, P13
[13]   Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests [J].
Crawley, JN .
BRAIN RESEARCH, 1999, 835 (01) :18-26
[14]   The substantia nigra of the human brain -: I.: Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D28K immunohistochemistry [J].
Damier, P ;
Hirsch, EC ;
Agid, Y ;
Graybiel, AM .
BRAIN, 1999, 122 :1421-1436
[15]   The substantia nigra of the human brain - II. Patterns of loss of dopamine-containing neurons in Parkinson's disease [J].
Damier, P ;
Hirsch, EC ;
Agid, Y ;
Graybiel, AM .
BRAIN, 1999, 122 :1437-1448
[16]   Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase [J].
Danielian, PS ;
Muccino, D ;
Rowitch, DH ;
Michael, SK ;
McMahon, AP .
CURRENT BIOLOGY, 1998, 8 (24) :1323-1326
[17]   Alterations in nigrostriatal dopaminergic function within BDNF mutant mice [J].
Dluzen, DE ;
Story, GM ;
Xu, K ;
Kucera, J ;
Walro, JM .
EXPERIMENTAL NEUROLOGY, 1999, 160 (02) :500-507
[18]  
Ernfors P, 1995, INT J DEV BIOL, V39, P799
[19]   Description of Parkinson's disease as a clinical syndrome [J].
Fahn, S .
PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON, 2003, 991 :1-14
[20]   A Drosophila model of Parkinson's disease [J].
Feany, MB ;
Bender, WW .
NATURE, 2000, 404 (6776) :394-398